Impax Laboratories Inc. and Amneal Pharmaceuticals LLC are close to agreement on a merger that would create the nation’s fifth-largest generic-drug company by revenue, according to people familiar with the matter.
NYS Entity Status
NYS Filing Date
MARCH 21, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2013 - COR ARSENAL STREET COMPANY, LLC
Around the Web
- Impax Laboratories and Amneal Pharmaceuticals Near Merger Agreement
Monday Oct 16, 2017
- N.Y. Company Accused of Running Bitcoin Ponzi Scheme
Thursday Sep 21, 2017
The CFTC has accused New York company Gelfman Blueprint of operating a bitcoin-related Ponzi scheme, in the regulator’s first fraud-related action involving the cryptocurrency.
- The Secret of Soccer's Best Super-Sub
Sunday Aug 13, 2017
Arsenal’s Olivier Giroud is the rare soccer player whose most dangerous position is starting every game on the bench.
- Dan Loeb's Third Point Makes Its Largest-Ever Bet With Nestlé Stake
Sunday Jun 25, 2017
Billionaire activist investor Daniel Loeb’s Third Point LLC hedge fund has taken a $3.5 billion stake in Nestlé SA, piling pressure on the world’s largest packaged foods company to find ways to accelerate growth.
- Trump Boasts U.S. Nuclear Arsenal Is 'More Powerful Than Ever'
Wednesday Aug 9, 2017
President Donald Trump boasted of the strength of the U.S. nuclear arsenal, vowing “there will never be a time that we are not the most powerful nation in the world.”
- Sixgill®, LLC Launches Sense 2.0
By Business Wire - Thursday Oct 12, 2017
PRESS RELEASE: Sixgill, LLC, the leader in sensor data services for governing IoE, today unveiled the next generation of its universal and highly scalable sensor data services platform, Sixgill Sense 2.0. Sense 2.0 provides vital capabilities...